BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Login Register Subscribe

Travelers predictive model aims to prevent chronic pain for injured workers


Travelers Cos. Inc. has developed a predictive model that identifies the likelihood of an injured worker developing chronic pain, the company said.

Travelers Early Severity Predictor, which was designed to mitigate chronic pain caused by workplace injuries, has been used in more than 20,000 cases since 2015, Travelers said in a statement on Tuesday.

The more than 9,000 injured workers who were identified as being at risk of developing chronic pain “received a customized, sports medicine-like regimen of treatment precisely sequenced to aid and accelerate their recovery,” according to the statement.

On average, injured workers who participated in Travelers Early Severity Predictor program recovered and returned to work faster and were less likely to receive opioids, the statement said, noting that injured workers who were prescribed opioids typically received a lower dosage and/or it was only for short-term use.

“When someone develops chronic pain, they are prescribed opioids or other painkillers more than 90% of the time,” Dr. Adam Seidner, national medical director at Travelers, said in the statement. “Our goal is to work with injured employees and their doctors to eliminate or substantially reduce the need for painkillers that can slow their recovery or lead to devastating long-term addiction.”

Read Next

  • State, federal efforts to curb opioid abuse set to grow

    Workers compensation professionals expect that efforts to curb opioid abuse will become more prevalent among state legislatures following passage of a new law in Massachusetts and the release of the U.S. Centers for Disease Control and Prevention's prescribing guideline.